CNS Therapeutics Receives $50,000 New Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=161f8c99-83e7-4361-8540-0678bb180c5f&Preview=1
Date
4/28/2011
Company Name
CNS Therapeutics
Mailing Address
332 Minnesota Street Saint Paul, MN 55101
Company Description
CNS Therapeutics develops and brings to market safe, high-quality pharmaceuticals for site-specific delivery to the central nervous system. Gablofen (baclofen injection) marks first breakthrough for CNS Therapeutics.
Website
http://www.gablofen.com
Transaction Type
Venture Equity
Transaction Amount
$50,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing – amended.
M&A Terms
Venture Investor
Undisclosed